The role of indoleamine 2,3-dioxygenase in LP-BPM5 murine retroviral disease progression

Virology Journal

Volumn 10, Issue , 2013, Pages

  O'Connor, Megan A ^a   Green, William R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Indoleamine 2,3 dioxygenase; LP BM5 murine retrovirus; Murine AIDS

Indexed keywords

CD11B ANTIGEN; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN M; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; MITOGENIC AGENT; PROGRAMMED DEATH 1 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; CD4+ T LYMPHOCYTE; CELL POPULATION; CONTROLLED STUDY; DISEASE COURSE; GENOTYPE; IMMUNE RESPONSE; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; RETROVIRUS INFECTION; SPLEEN CELL; SPLENOMEGALY; VIRUS IMMUNITY; VIRUS LOAD;

MURINAE; MUS;

EID: 84877819805     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-154     Document Type: Article

References (63)

1. A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation. Baban B, Hansen AM, Chandler PR, Manlapat A, Bingaman A, Kahler DJ, Int Immunol 2005 17 909 919 10.1093/intimm/dxh271 15967784
2. Regulatory T-cell markers, indoleamine 2,3-dioxygenase, and virus levels in spleen and gut during progressive simian immunodeficiency virus infection. Boasso A, Vaccari M, Hryniewicz A, Fuchs D, Nacsa J, Cecchinato V, J Virol 2007 81 11593 11603 10.1128/JVI.00760-07 17715231
3. Control of immune response by amino acid metabolism. Grohmann U, Bronte V, Immunol Rev 2010 236 243 264 10.1111/j.1600-065X.2010.00915.x 20636821
4. Indoleamine 2,3 dioxygenase and regulation of T cell immunity. Mellor A, Biochem Biophys Res Commun 2005 338 20 24 10.1016/j.bbrc.2005.08.232 16157293
5. Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells. Manlapat AK, Kahler DJ, Chandler PR, Munn DH, Mellor AL, Eur J Immunol 2007 37 1064 1071 10.1002/eji.200636690 17343295
6. Physiologic control of IDO competence in splenic dendritic cells. Baban B, Chandler PR, Johnson BA 3rd, Huang L, Li M, Sharpe ML, J Immunol 2011 187 2329 2335 10.4049/jimmunol.1100276 21813777
7. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Mellor AL, Munn DH, Nat Rev Immunol 2004 4 762 774 10.1038/nri1457 15459668
8. T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase. Kahler DJ, Mellor AL, Handb Exp Pharmacol 2009 188 165 196 10.1007/978-3-540-71029-5-8 19031026
9. Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines. MacKenzie CR, Heseler K, Müller A, Däubener W, Curr Drug Metab 2007 8 237 244 10.2174/138920007780362518 17430112
10. On watching the watchers: IDO and type I/II IFN. Puccetti P, Eur J Immunol 2007 37 876 879 10.1002/eji.200737184 17393386
11. Interactions between nitric oxide and indoleamine 2,3-dioxygenase. Samelson-Jones BJ, Yeh S-R, Biochemistry 2006 45 8527 8538 10.1021/bi060143j 16834326
12. Indoleamine 2,3-dioxygenase: is it an immune suppressor? Soliman H, Mediavilla-Varela M, Antonia S, Cancer J 2010 16 354 359 10.1097/PPO. 0b013e3181eb3343 20693847
13. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Favre D, Mold J, Hunt PW, Kanwar B, Loke P, Seu L, Sci Transl Med 2010 2 32ra36 10.1126/scitranslmed.3000632 20484731
14. Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling. Mellor AL, Baban B, Chandler PR, Manlapat A, Kahler DJ, Munn DH, J Immunol 2005 175 5601 5605 16237046
15. Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape. Katz JB, Muller AJ, Prendergast GC, Immunol Rev 2008 222 206 221 10.1111/j.1600-065X.2008.00610.x 18364004
16. High activity of indoleamine 2,3-dioxygenase is associated with renal insufficiency in Puumala hantavirus induced nephropathia epidemica. Outinen TK, Mäkelä SM, Ala-Houhala IO, Huhtala HSA, Hurme M, Libraty DH, J Med Virol 2011 83 731 737 10.1002/jmv.22018 21328391
17. Malaria parasite induces tryptophan-related immune suppression in mice. Tetsutani K, To H, Torii M, Hisaeda H, Himeno K, Parasitology 2007 134 923 930 10.1017/S0031182007002326 17316473
18. Leishmania major attenuates host immunity by stimulating local indoleamine 2,3-dioxygenase expression. Makala LHC, Baban B, Lemos H, El-Awady AR, Chandler PR, Hou D-Y, J Infect Dis 2011 203 715 725 10.1093/infdis/jiq095 21282196
19. Interferon-induced indoleamine 2,3-dioxygenase activity inhibits Chlamydia psittaci replication in human macrophages. Carlin JM, Borden EC, Byrne GI, J Interferon Res 1989 9 329 337 10.1089/jir.1989.9.329 2501398
20. Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2, 3-dioxygenase activity. Pantoja LG, Miller RD, Ramirez JA, Molestina RE, Summersgill JT, Infect Immun 2000 68 6478 6481 10.1128/IAI.68.11.6478-6481.2000 11035763
21. Influence of tryptophan contained in 1-methyl-tryptophan on antimicrobial and immunoregulatory functions of indoleamine 2,3-dioxygenase. Schmidt SK, Siepmann S, Kuhlmann K, Meyer HE, Metzger S, Pudelko S, PLoS One 2012 7 44797 10.1371/journal.pone.0044797 23028625
22. Inhibition of human herpes simplex virus type 2 by interferon gamma and tumor necrosis factor alpha is mediated by indoleamine 2,3-dioxygenase. Adams O, Besken K, Oberdörfer C, MacKenzie CR, Rüssing D, Däubener W, Microbes Infect 2004 6 806 812 10.1016/j.micinf.2004.04.007 15374002
23. Role of IFN-γ indoleamine 2,3-dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells. Bodaghi B, Goureau O, Zipeto D, Laurent L, Virelizier J-L, Michelson S, J Immunol 1999 162 957 964 9916720
24. Role of indoleamine 2,3-dioxygenase in antiviral activity of interferon-gamma against vaccinia virus. Terajima M, Leporati AM, Viral Immunol 2005 18 722 729 10.1089/vim.2005.18.722 16359238
25. Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells. Mao R, Zhang J, Jiang D, Cai D, Levy JM, Cuconati A, J Virol 2011 85 1048 1057 10.1128/JVI.01998-10 21084489
26. Monitoring tryptophan metabolism in chronic immune activation. Schröcksnadel K, Wirleitner B, Winkler C, Fuchs D, Clin Chim Acta 2006 364 82 90 10.1016/j.cca.2005.06.013 16139256
27. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Boasso A, Herbeuval J-P, Hardy AW, Anderson SA, Dolan MJ, Fuchs D, Blood 2007 109 3351 3359 10.1182/blood-2006-07-034785 17158233
28. Overactivation of plasmacytoid dendritic cells inhibits antiviral T-cell responses: a model for HIV immunopathogenesis. Boasso A, Royle CM, Doumazos S, Aquino VN, Biasin M, Piacentini L, Blood 2011 118 5152 5162 10.1182/blood-2011- 03-344218 21931112
29. HIV-1 Tat activates indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures in a p38 mitogen-activated protein kinase-dependent manner. Fu X, Lawson MA, Kelley KW, Dantzer R, J Neuroinflammation 2011 8 88 10.1186/1742-2094-8-88 21810259
30. Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. Bosinger SE, Li Q, Gordon SN, Klatt NR, Duan L, Xu L, J Clin Invest 2009 119 3556 3572 19959874
31. The absence of IDO upregulates type I IFN production, resulting in suppression of viral replication in the retrovirus-infected mouse. Hoshi M, Saito K, Hara A, Taguchi A, Ohtaki H, Tanaka R, J Immunol 2010 185 3305 3312 10.4049/jimmunol.0901150 20693424
32. Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection. Fuchs D, Möller AA, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP, Immunol Lett 1991 28 207 211 10.1016/0165-2478(91)90005-U 1909303
33. Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis. Potula R, Poluektova L, Knipe B, Chrastil J, Heilman D, Dou H, Blood 2005 106 2382 2390 10.1182/blood-2005-04-1403 15961516
34. Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice. Mosier DE, Yetter RA, Morse HC 3rd, J Exp Med 1985 161 766 784 10.1084/jem.161.4.766 2984305
35. Abrogation of resistance to severe mousepox in C57BL/6 mice infected with LP-BM5 murine leukemia viruses. Buller RM, Yetter RA, Fredrickson TN, Morse HC 3rd, J Virol 1987 61 383 387 3027368
36. Characteristics of B cell proliferation and activation in murine AIDS. Klinman DM, Morse HC 3rd, J Immunol 1989 142 1144 1149 2464640
37. Immune CD8(+) T cells prevent reactivation of Toxoplasma gondii infection in the immunocompromised host. Khan IA, Green WR, Kasper LH, Green KA, Schwartzman JD, Infect Immun 1999 67 5869 5876 10531242
38. An alternative translational reading frame encodes an immunodominant retroviral CTL determinant expressed by an immunodeficiency-causing retrovirus. Mayrand SM, Schwarz DA, Green WR, J Immunol 1998 160 39 50 9551954
39. Functional T lymphocytes are required for a murine retrovirus-induced immunodeficiency disease (MAIDS). Mosier DE, Yetter RA, Morse HC 3rd, J Exp Med 1987 165 1737 1742 10.1084/jem.165.6.1737 3035057
40. Cytolytic CD8+ T cells directed against a cryptic epitope derived from a retroviral alternative reading frame confer disease protection. Ho O, Green WR, J Immunol 2006 176 2470 2475 16456007
41. Defining the mechanism(s) of protection by cytolytic CD8 T cells against a cryptic epitope derived from a retroviral alternative reading frame. Rutkowski MR, Ho O, Green WR, Virology 2009 390 228 238 10.1016/j.virol.2009.05.003 19539970
42. Alternative translational reading frames as a novel source of epitopes for an expanded CD8 T-cell repertoire: use of a retroviral system to assess the translational requirements for CTL recognition and lysis. Carlson TL, Green KA, Green WR, Viral Immunol 2010 23 577 583 10.1089/vim.2010.0057 21142443
43. The programmed death-1 and interleukin-10 pathways play a down modulatory role in LP-BM5 retrovirus-induced murine immunodeficiency syndrome. Green KA, Okazaki T, Honjo T, Cook WJ, Green WR, J Virol 2008 82 2456 2469 10.1128/JVI.01665-07 18094175
44. Immunotherapy of murine retrovirus-induced acquired immunodeficiency by CD4 T regulatory cell depletion and PD-1 blockade. Li W, Green WR, J Virol 2011 85 13342 13353 10.1128/JVI.00120-11 21917983
45. Tsl and LP-BM5: a comparison of two murine retrovirus models for HIV. Clark S, Duggan J, Chakraborty J, Viral Immunol 2001 14 95 109 10.1089/088282401750234475 11398815
46. Myeloid-derived suppressor cells in murine retrovirus-induced AIDS: inhibition of the T-cell and B-cell responsiveness that define the immunodeficiency. Green KA, Cook WJ, Green WR, J Virol 2013 87 4 2058 2071 10.1128/JVI.01547-12 23221564
47. Differential regulation of indoleamine 2,3-dioxygenase expression by nitric oxide and inflammatory mediators in IFN-gamma-activated murine macrophages and microglial cells. Alberati-Giani D, Malherbe P, Ricciardi-Castagnoli P, Köhler C, Denis-Donini S, Cesura AM, J Immunol 1997 159 419 426 9200481
48. Inhibition of nitric oxide synthase expression and activity in macrophages by 3-hydroxyanthranilic acid, a tryptophan metabolite. Sekkaï D, Guittet O, Lemaire G, Tenu JP, Lepoivre M, Arch Biochem Biophys 1997 340 117 123 10.1006/abbi.1997.9913 9126284
49. The CD154/CD40 interaction required for retrovirus-induced murine immunodeficiency syndrome is not mediated by upregulation of the CD80/CD86 costimulatory molecules. Green KA, Cook WJ, Sharpe AH, Green WR, J Virol 2002 76 13106 13110 10.1128/JVI.76.24.13106-13110.2002 12438641
50. CD19 signaling pathways play a major role for murine AIDS induction and progression. Knoetig SM, Torrey TA, Naghashfar Z, McCarty T, Morse HC 3rd, J Immunol 2002 169 5607 5614 12421939
51. The role of CD4 T cells in the pathogenesis of murine AIDS. Li W, Green WR, J Virol 2006 80 5777 5789 10.1128/JVI.02711-05 16731917
52. Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections. Adams O, Besken K, Oberdörfer C, MacKenzie CR, Takikawa O, Däubener W, J Virol 2004 78 2632 2636 10.1128/JVI.78.5.2632-2636.2004 14963171
53. Antimicrobial and immunoregulatory effects mediated by human lung cells: role of IFN-gamma-induced tryptophan degradation. Heseler K, Spekker K, Schmidt SK, MacKenzie CR, Däubener W, FEMS Immunol Med Microbiol 2008 52 273 281 10.1111/j.1574-695X.2007.00374.x 18205804
54. The neurotoxin quinolinic acid is increased in spinal cords of mice with herpes simplex virus encephalitis. Reinhard JF Jr, Flanagan EM, Adv Exp Med Biol 1996 398 241 246 10.1007/978-1-4613-0381-7-37 8906271
55. Opposing biological functions of tryptophan catabolizing enzymes during intracellular infection. Divanovic S, Sawtell NM, Trompette A, Warning JI, Dias A, Cooper AM, J Infect Dis 2012 205 152 161 10.1093/infdis/jir621 21990421
56. HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation. Boasso A, Hardy AW, Anderson SA, Dolan MJ, Shearer GM, PLoS One 2008 3 2961 10.1371/journal.pone.0002961 18698365
57. Combined effect of antiretroviral therapy and blockade of IDO in SIV-infected rhesus macaques. Boasso A, Vaccari M, Fuchs D, Hardy AW, Tsai W-P, Tryniszewska E, J Immunol 2009 182 4313 4320 10.4049/jimmunol.0803314 19299731
58. Preclinical evaluation of HIV eradication strategies in the simian immunodeficiency virus-infected rhesus macaque: A pilot study testing inhibition of indoleamine 2,3-dioxygenase. Dunham RM, Gordon SN, Vaccari M, Piatak M, Huang Y, Deeks SG, AIDS Res Hum Retroviruses 2012 29 2 207 214 22924680
59. Evolution of B cell lineage lymphomas in mice with a retrovirus-induced immunodeficiency syndrome, MAIDS. Klinken SP, Fredrickson TN, Hartley JW, Yetter RA, Morse HC 3rd, J Immunol 1988 140 1123 1131 2830334
60. Evidence for a continued requirement for CD40/CD40 ligand (CD154) interactions in the progression of LP-BM5 retrovirus-induced murine AIDS. Green KA, Noelle RJ, Green WR, Virology 1998 241 260 268 10.1006/viro.1997.8970 9499800
61. Characterization of the CD154-positive and CD40-positive cellular subsets required for pathogenesis in retrovirus-induced murine immunodeficiency. Green KA, Noelle RJ, Durell BG, Green WR, J Virol 2001 75 3581 3589 10.1128/JVI.75.8.3581-3589.2001 11264347
62. Impaired memory CD8 T cell responses against an immunodominant retroviral cryptic epitope. Rutkowski MR, Stevens CA, Green WR, Virology 2011 412 256 268 10.1016/j.virol.2010.11.013 21295815
63. Quantitative analysis of LP-BM5 murine leukemia retrovirus RNA using real-time RT-PCR. Cook WJ, Green KA, Obar JJ, Green WR, J Virol Methods 2003 108 49 58 10.1016/S0166-0934(02)00256-2 12565153